BRPI0413287A - métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa) - Google Patents

métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa)

Info

Publication number
BRPI0413287A
BRPI0413287A BRPI0413287-4A BRPI0413287A BRPI0413287A BR PI0413287 A BRPI0413287 A BR PI0413287A BR PI0413287 A BRPI0413287 A BR PI0413287A BR PI0413287 A BRPI0413287 A BR PI0413287A
Authority
BR
Brazil
Prior art keywords
dog
osteoarthritis
methods
likelihood
epa
Prior art date
Application number
BRPI0413287-4A
Other languages
English (en)
Inventor
Dale A Fritsch
Dennis E Jewell
William D Schoenherr
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BRPI0413287A publication Critical patent/BRPI0413287A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feed For Specific Animals (AREA)

Abstract

"MéTODOS DE RESTAURAR UMA FUNçãO DA ARTICULAçãO QUE é MAIS PRóXIMA DO NORMAL EM UM CãO APRESENTANDO OSTEOARTRITE, E DE ELIMINAR A PROBABILIDADE DE UM CãO DESENVOLVER OSTEOARTRITE, E, USO DE áCIDO EICOSAPENTAENóICO (EPA)". Divulga-se métodos para restaurar uma função de articulação mais próxima do normal em um cão osteoartrítico, e métodos de eliminar a probabilidade de um cão desenvolver osteoartrite. Os métodos podem compreender administrar aos cães uma composição compreendendo uma concentração efetiva do ácido graxo ómega 3, ácido eicosapentaenóico.
BRPI0413287-4A 2003-08-11 2004-08-10 métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa) BRPI0413287A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63883203A 2003-08-11 2003-08-11
PCT/US2004/025759 WO2005018630A1 (en) 2003-08-11 2004-08-10 Omega-3 fatty acids for the treatment of canine ostheoarthritis

Publications (1)

Publication Number Publication Date
BRPI0413287A true BRPI0413287A (pt) 2006-10-10

Family

ID=34216315

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413287-4A BRPI0413287A (pt) 2003-08-11 2004-08-10 métodos de restaurar uma função da articulação que é mais próxima do normal em um cão apresentando osteoartrite, e de eliminar a probabilidade de um cão desenvolver osteoartrite, e, uso de ácido eicosapentaenóico (epa)

Country Status (14)

Country Link
EP (1) EP1656130B1 (pt)
JP (2) JP2007502276A (pt)
CN (2) CN101653436B (pt)
AT (1) ATE402695T1 (pt)
AU (1) AU2004266601B2 (pt)
BR (1) BRPI0413287A (pt)
CA (1) CA2529749C (pt)
DE (1) DE602004015472D1 (pt)
DK (1) DK1656130T3 (pt)
ES (1) ES2310757T3 (pt)
MX (1) MXPA05013757A (pt)
RU (1) RU2422140C2 (pt)
WO (1) WO2005018630A1 (pt)
ZA (1) ZA200601096B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
RU2351153C2 (ru) * 2004-07-01 2009-04-10 Нестек С.А. Композиция диеты при остеоартрите собак
BRPI0713572A2 (pt) * 2006-06-20 2012-10-23 Stephen Duguay meios livres de soro e seus usos para expansão de condrócitos
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN102159197A (zh) * 2008-07-18 2011-08-17 希尔氏宠物营养品公司 治疗骨关节炎的组合物和方法
CN103384521A (zh) * 2010-12-21 2013-11-06 雀巢产品技术援助有限公司 用于预防和治疗骨关节炎的方法和组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
EG22407A (en) * 2000-02-17 2003-01-29 Iams Company Method for improving bone modeling and chondrocyte functioning in growing canines

Also Published As

Publication number Publication date
RU2422140C2 (ru) 2011-06-27
CA2529749A1 (en) 2005-03-03
CN101653436A (zh) 2010-02-24
CN101653436B (zh) 2017-06-09
DE602004015472D1 (de) 2008-09-11
CN100558352C (zh) 2009-11-11
AU2004266601B2 (en) 2011-03-24
ES2310757T3 (es) 2009-01-16
DK1656130T3 (da) 2008-11-24
RU2006107197A (ru) 2006-06-27
AU2004266601A1 (en) 2005-03-03
ATE402695T1 (de) 2008-08-15
CN1835745A (zh) 2006-09-20
EP1656130B1 (en) 2008-07-30
CA2529749C (en) 2012-03-20
ZA200601096B (en) 2007-04-25
MXPA05013757A (es) 2006-03-08
JP2007502276A (ja) 2007-02-08
JP2012116865A (ja) 2012-06-21
WO2005018630A1 (en) 2005-03-03
EP1656130A1 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
ECSP088461A (es) Composiciones farmacéuticas que contienen buprenorfina
EA200700240A1 (ru) Композиция, содержащая статины и омега - 3 жирные кислоты
BRPI0609711B8 (pt) uso de uma solução aquosa com potencial redutivo oxidativo (orp)
AR073485A1 (es) Composiciones nutricionales con globulos lipidicos de gran tamano
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
BRPI0713377A2 (pt) formulação nutritiva, e, uso de uma formulação
ID21473A (id) Sediaan farmasi yang mengandung asam eikosapentanoat dan asam stearidonat
AR039170A1 (es) Co-granulos de dha y romero y metodos de uso
EA200801602A1 (ru) Эмульсия
AR056816A1 (es) Composicion con ácido docosapentenoico
ECSP003847A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
AR038375A1 (es) Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
BRPI0405948A (pt) Representação gráfica, armazenamento e disseminação de pensamento exposto
ATE442146T1 (de) Pharmazeutische zusammensetzung mit prostaglandin
Jang et al. Substitution effect of sea tangle (ST)(Laminaria japonica) with tunic of sea squirt (SS)(Halocynthia roretzi) in diet on growth and carcass composition of juvenile abalone (Haliotis discus, Reeve 1846)
HRP20201141T1 (hr) Nutritivna kompozicija za primjenu u terapiji pacijenata sa sarkopenijom i/ili slabošću ili pacijenta sa presarkopenijom i/ili pred-slabošću
AR054255A1 (es) Tratamiento de la disfuncion intestinal enpacientes con hiv
Arslan et al. Effects of different dietary lipid sources on the survival, growth, and fatty acid composition of South American catfish, Pseudoplatystoma fasciatum, surubim, juveniles
DK0808154T3 (da) Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer
KR930003835A (ko) n-3 지방산이 축적된 돈육 생산용 사료조성물
Estévez et al. Organic production of gilthead sea bream (Sparus aurata) using organic certified green pea protein and seaweed. Effects on growth, feed conversion and final product quality.
DK1656130T3 (da) Omega-3-fedtsyrer til behandling af osteoarthritis hos hunde
Karalazos et al. Effects of fish meal replacement with full-fat soy meal on growth and tissue fatty acid composition in Atlantic cod (Gadus morhua)
DK59782A (da) Anvendelse af vandige natrium- eller kalium-methioninatoploesninger til supplering af blandingsfoder med methionin
AR045853A1 (es) Metodo y composicion para mejorar la capacidad de aprender en un cachorro o gatito

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/201 (2006.01), A23K 20/158 (2016.01), A23K